NEW YORK, NY / ACCESSWIRE / November 25, 2024 / Acreage Holdings, Inc. ("Acreage" or the "Company") (CSE:ACRG.A.U, ACRG.B.U)(OTCQX:ACRHF, ACRDF), a vertically integrated, multi-state operator of ...

TORONTO, ON / ACCESSWIRE / November 25, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (the "Company") formerly named FSD Pharma Inc. (Nasdaq:HUGE)(CSE:HUGE) is pleased to follow up ...

CAMBRIDGE, MA / ACCESSWIRE / November 25, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:7th Annual Evercore ISI HealthCONx ...

Mergers & AcquisitionsSYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry 25.11.2024 / 11:39 CET/CESTThe issuer is solely responsible for the content of this ...

VANCOUVER, BC / ACCESSWIRE / November 25, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce the expansion of its next-generation ...

Change in ForecastEckert & Ziegler raises its forecast for the current financial year once again22-Nov-2024 / 15:27 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation ...

Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer ...

VANCOUVER, BC / ACCESSWIRE / November 22, 2024 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ)(OTC PINK:FRECF) is pleased to announce former NHL star, Hockey Hall of ...

FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts. This state-of-the-art facility is ...

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP inhibitor drug, olaparib, according to new research published in the journal ...

(Hong Kong, 21 November 2024) – Modern Dental Group Limited (the "Modern Dental Group" or the "Group", Stock Code: 03600.HK), a leading global dental prosthetics provider, is pleased to announce the ...